Your browser doesn't support javascript.
loading
Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.
von Tresckow, Bastian; Kreissl, Stefanie; Goergen, Helen; Bröckelmann, Paul J; Pabst, Thomas; Fridrik, Michael; Rummel, Mathias; Jung, Wolfram; Thiemer, Julia; Sasse, Stephanie; Bürkle, Carolin; Baues, Christian; Diehl, Volker; Engert, Andreas; Borchmann, Peter.
Afiliación
  • von Tresckow B; German Hodgkin Study Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.
  • Kreissl S; German Hodgkin Study Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.
  • Goergen H; German Hodgkin Study Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.
  • Bröckelmann PJ; German Hodgkin Study Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.
  • Pabst T; Swiss Group for Clinical Cancer Research, Bern, Switzerland; Department of Medical Oncology, University Hospital, Bern, Switzerland.
  • Fridrik M; Arbeitsgemeinschaft Medikamentöse Tumortherapie, Salzburg, Austria; Department of Internal Medicine III, Kepler Universitätsklinikum, Linz, Austria.
  • Rummel M; Department of Hematology/Oncology, Klinikum der Justus-Liebig-Universität, Gießen, Germany.
  • Jung W; Department of Haematology and Medical Oncology, University Hospital Göttingen, Göttingen, Germany.
  • Thiemer J; Clinic for Hematology, Oncology and Immunology, Philipps University, Marburg, Germany.
  • Sasse S; German Hodgkin Study Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.
  • Bürkle C; German Hodgkin Study Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.
  • Baues C; Department of Radiotherapy, University Hospital of Cologne, Cologne, Germany.
  • Diehl V; German Hodgkin Study Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.
  • Engert A; German Hodgkin Study Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.
  • Borchmann P; German Hodgkin Study Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany. Electronic address: peter.borchmann@uni-koeln.de.
Lancet Haematol ; 5(10): e462-e473, 2018 Oct.
Article en En | MEDLINE | ID: mdl-30290903
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedad de Hodgkin Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Haematol Año: 2018 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedad de Hodgkin Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Haematol Año: 2018 Tipo del documento: Article País de afiliación: Alemania